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ABSTRACT
The prevalence of cutaneous mast cell sarcomas (MCSs) was investigated at the Department of Veterinary 
Pathology of the Faculty of Veterinary Medicine from January 1st, 2008 to December 31st, 2012. The frequency 
of tumor grades was established in relation to the breed, sex and localization in Croatia. In the analyzed period a 
total of 1939 tumors were diagnosed, of which 928 were skin tumors, and MCS were found in 125 animals, or in 
13.47% of skin tumors. MCSs were found more frequently in male dogs (n = 77 or 61.6%) and the average age 
was 7.83 years. A higher incidence of these tumors were on the thorax (16.8%), hind limbs (12.8%), abdomen 
(12%), head (9.6%), forelimb (7.20%) and neck (6.4%). Golden Retrievers, mongrels and Boxers were the 
most frequent breeds. Grade I tumors were found in 24.8% (n = 31) of animals, of which 67.74% (n = 21) were 
male and 32.26 (n = 10) female; grade II was found in 41.6% (n = 52) of which 59.62% (n = 31) were male and 
40.38% (n = 21) female; and grade III was found in 33.6% (n = 42) of which 59.53% (n = 25) were male and 
40.44 (n = 17) female. The percentage of grades I, II and III in male dogs was 27.27%, 40.26% and 32.47% 
respectively and in females 20.83%; 43.75% and 35.42% respectively. The average age of dogs with grade I, 
II and III tumors was 7.82, 7.69, and 7.99 years respectively. The most frequent on the head was grade II, on 
the neck grades I and III equally, and on the forelimbs, hind limbs, back, abdomen, tail and preputium grade II 
was most frequent. The most frequent grade on the perineum, scrotum and multiple locations was grade III. In 
the Golden Retrievers the most frequent location of tumors was the thorax, in the mongrels there were multiple 
locations and in Boxers the abdomen was most frequent.
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Introduction
Cancer has a very important role as a cause of death in dogs, especially older 
ones. In total 23% of all dogs die from tumors (WITHROW, 1996). One of these is a 
mast cell sarcoma (MCS), commonly encountered in small animal practice. The data 
about the incidence of MCSs differ. MCS accounts for 7-27% of skin neoplasms in dogs 
(BRODEY, 1970; PRIESTER, 1973; FINNIE and BOSTOCK, 1979; ROTHWELL et al., 1987; 
GOLDSCHMIDT and SHOFER, 1998; FOX, 1998; MISDORP, 2004; BLACKWOOD et al., 
2012). Mast cell tumors are neoplastic proliferations of mast cells and should always 
be considered in the list of differential diagnoses for a skin mass (BLACKWOOD et al., 
2012). The majority of canine MCT (mast cell tumors) occurs in the skin and subcutis, 
and they arise from tissue mast cells in the dermis and subcutaneous tissues. Tumors are 
usually solitary but may be multicentric. Multiple tumors occur in about 10% to 15% of 
cases (LONDON and SEGUIN, 2003). Clinically, mast cell tumors are generally alopecic, 
erythematous, edematous nodules that vary in size from several millimeters to several 
centimeters, and ulcerations are often present in larger tumors (GROSS et al., 2010).
MCSs most commonly occur in middle-aged and older dogs, with a mean age from 
6.96 to 9 years, but they were also recorded in dogs under 1 year (GRABAREVIĆ et al., 
2009; GROSS et al., 2010; BLACKWOOD et al., 2012; ŠOŠTARIĆ-ZUCKERMANN, 2013). 
There is no sex predisposition (GOLDSCHMIDT and SHOFER, 1998; BLACKWOOD et. al., 
2012) but there is breed predilection in Boxers, Retrievers, Pugs, Boston terriers and Pit-
bull terriers. In Boxers and Pugs MCSs are grade I or II with more favorable prognosis 
in Shar Peis.1 Younger animals (MILLER, 1995) are also predisposed to developing 
MCSs but these are often poorly differentiated and more aggressive (O’KEEFE, 1990; 
LONDON and SEGUIN, 2003; McNEIL et al., 2006; MULLINS et al., 2006; GRABAREVIĆ et 
al., 2009; GROSS et al., 2010). RABANAL and FERRER (2002) reported that 50% of MCSs 
in dogs appear on the trunk, 40% on the extremities, and 10% on the head. MCSs in the 
perineal region, scrotum, prepuce and digits are more aggressive (SCOTT et al., 2001) but 
GIEGER et al. (2003) described an increased regional metastatic rate of facial MCSs when 
compared with MCSs in other locations. It has been reported that certain predilection 
locations are associated with a particular breed. For example, Boxers, Boston Terriers, 
Pugs, English Setters and American Staffordshire Terriers tend to have tumors on the hind 
legs, Rhodesian Ridgebacks on the tail and English Setters often have tumors on the head 
(GOLDSCHMIDT and SHOFER, 1998).
Many MCS originate in the dermis and extend into the subcutis, but there is a subset 
that is restricted to the subcutaneous fat. This type has been described by NEWMAN et 
al. (2007) and THOMPSON et al. (2011). Results of a study conducted by THOMPSON et al. 
(2011) indicate that the majority of dogs with subcutaneous MCSs had prolonged survival 
rates, and decreased rates of local reoccurrence and metastasis than those reported for 
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grade II cutaneous MCSs. Subcutaneous tumors are more effectively controlled by 
surgery alone than their cutaneous counterparts. The most commonly used grading system 
was developed by PATNAIK et al. (1984) in which there are three different tumor grades, 
classifi ed from I to III, with grade III as the most aggressive type. The histopathological 
grading is subjective, which results in variations between pathologists. The concordance 
among pathologists was 74% for the diagnosis of grade III MCT and less than 64% for 
diagnosis of grade I and II (NORTHRUP et al., 2005a and 2005b; KIUPEL et al., 2011). The 
major difference between grade I and grade II MCSs in this system is the extension of 
neoplastic cells into the subcutis (PATNAIK et al., 1984). To improve concordance between 
pathologists, a two-tier histological grading system has been proposed, which uses more 
specifi c and precise histological grading criteria, and eliminates the ambiguity of the 
intermediate grade. This grading includes high grade and low grade MCSs (KIUPEL et 
al., 2011). The diagnosis of high-grade MCSs is based on the presence of any one of the 
following criteria: at least 7 mitotic fi gures in 10 high-power fi elds (HPF); at least 3 
multinucleated (3 or more nuclei) cells in 10 HPF; at least 3 bizarre nuclei in 10 HPF; 
karyomegaly (i. e. nuclear diameters of at least 10% neoplastic cells vary by at least two-
fold). All other tumors are considered low grade (BLACKWOOD et al., 2012).
The aim of this study was to compile and present data on canine MCSs diagnosed in 
Croatia in the 2008-2012 period, and to compare these data with the literature. Another 
goal was to suggest the potential application of a two-tier histological grading system as 
a tool for veterinary pathologists to assess the potential biological behavior of MCSs in 
dogs. It seems this grading system provides more prognostic information than Patnaik’s 
3-tier grading system. 
Materials and methods
A retrospective study was performed at the Department of Veterinary Pathology, 
Faculty of Veterinary Medicine, University of Zagreb, in the period from January 1st, 2008 
to December 31st 2012, using all tumors in dogs presented for histopathological analysis, 
and all subcutaneous MCSs. Diagnoses were established by experienced veterinary 
pathologists using histopathologic evaluation of standard H&E stained microscopic 
slides. If the diagnosis was suspected, differential staining (Toluidine blue stain) was 
used to establish metacromasia of the mastocyte granules. The Patnaik system was used 
for histopathological grading of cutaneous MCSs. The incidence and distribution of this 
tumor in dogs, in relation to the sex, age, breed, grade and localization in Croatia were 
investigated. Statistical analysis of collected data was performed in Microsoft Offi ce 
Excel. 
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Results
During the investigated period a total of 1939 different tumors in dogs (n = 983 or 
50.70% in male dogs; n = 956 or 49.30% in female dogs) were diagnosed, of which 928 
(n = 548 or 59.05% in male dogs; n = 380 or 40.95% in female dogs) cases were skin 
tumors. Of those, in 125 (n = 77 or 61.6% in male dogs; n = 48 or 38.4% in female dogs) 
animals mast cell tumors were found (Table 1). The dogs in this study ranged from 2 to 
14 years of age. The mean age of the affected animals was 7.83 years (Table 2). Age was 
not recorded in fourteen cases.
Table 1. Frequency of mast cell sarcoma in relation to the total number of tumors and total 
number of skin tumors
Year
Total number of all tumors 
(n+%) (F+M) Skin tumors (n+%) (F+M) MCT (n+%) (F+M)
2008 397 (20.47%) (181F+216M) (45.59%F+54.41%M)
214 (23.96%) (148F+66M) 
(69.16%F+30.84%M)
16 (7.48%) (5F+11M) 
31.25%F+68.75%M)
2009 395 /20.37%) (214F+181M) (54.18%F+45.82%M)
156 (16.35%) (60F+96M) 
38.46%F+61.54%M)
21 (13.46%) (13F+8M) 
(61.9%F+38.1%M)
2010 377 (19.44%) (198F+179M) (52.52%F+47.48%M)
176 (18.43%) (55F+121M) 
(31.25%F+68.75%M)
27 (15.34%) (12F+15M) 
(44.4%F+55.6%M)
2011 360 (18.57%) (178F+182M) (49.44%F+50.56%M)
184 (17.34) (63F+121M) 
(34.24%F+65.76%M)
24 (13.04%) (9F+15M) 
(37.5%F+62.5%M)
2012 410 (21.14%) (185F+225M) (45.12%F+54.88%M)
198 (16.56%) (54F+144M) 
27.27%F+72.73%M)
37 (18.67%) 9F+28M 
(24.32%F+75.68%M)
Total 1939 (956F+983M) 49.30%F+50.70%M
928 (47.86%) (380F+548M) 
(40.95%F+59.05%M)
125 (13.47%) (48F+77M) 
(38.4%F+61.6%M)
Table 2. Frequency of mast cell sarcoma in relation to sex and age
Year Total Male Female Age
2008 16 11 (68.75%)  5 (31.25%) 7.72
2009 21  8 (38.10%) 13 (61.90%) 7.12
2010 27 15 (55.56%) 12 (4.44%) 7.77
2011 24 15 (62.5%)  9 (37.5%) 8.75
2012 37 28 (75.68%)  9 (24.32%) 7.80
Total 125 77 (61.6%) 48 (38.4%) 7.83
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125 Male Female Total Male Female Total Male Female Total
Golden Retriever 26 (20.8%) 2 2 4 (15.38%) 5 9 14 (53.85) 6 2 8 (30.77%)
Mongrel 19 (15.2%) 4 2 6 (31.58%) 4 2 6 (31.58) 5 2 7 (36.84%)
Boxer 14 (11.2%) 4 2 6 (42.86%) 2 3 5 (35.71) 1 2 3 (21.43%)
Labrador
Retriever 12 (9.6%) 1 2 3 (25%) 2 2 4 (33.33) 1 4 5 (41.67%)
Pug 7 (5.6%) 2 0 2 (28.7%) 4 0 4 (57.14) 1 0 1 (14.29%)
Staffordshire 
Terrier 7 (5.6%) 0 0 0 (0%) 4 1 5 (71.43) 1 1 2 (28.57%)
Not known 4 (3.2%) 0 0 0 (0%) 2 0 2 (50%) 2 0 2 (50%)
Bullmastiff 4 (3.2%) 1 0 1 (25%) 2 0 2 (50%) 1 0 1 (25%)
Shar Pei 2 (1.6%) 2 0 2 (100%) 0 0 0 (0%) 0 0 0 (0%)
English Setter 2 (1.6%) 1 1 2 (100%) 0 0 0 (0%) 0 0 0 (0%)
Rottweiller 2 (1.6%) 0 0 0 (0%) 0 1 1 (50%) 0 1 1 (50%)
Maltese 2 (1.6%) 0 0 0 (0%) 2 0 2 (100%) 0 0 0 (0%)
Fox Terrier 2 (1.6%) 0 0 0 (0%) 2 0 2 (100%) 0 0 0 (0%)
Boston Terrier 2 (1.6%) 1 0 1 (50%) 0 0 0 (0%) 1 0 1 (50%)
Bernese 
Mountain Dog 2 (1.6%) 0 0 0 (0%) 0 0 0 (0%) 2 0 2 (100%)
Lassa Apsso 2 (1.6%) 2 0 2 (100%) 0 0 0 (0%) 0 0 0 (0%)
German Shepherd 
Dog 2 (1.6%) 1 0 1 (50%) 0 0 0 (0%) 1 0 1 (50%)
Dalmatian 1 (0.8%) 0 0 0 (%) 1 0 1 (100%) 0 0 0 (0%)
Rhodesian 
Ridgeback 1 (0.8%) 0 1 1 (100%) 0 0 0 (0%) 0 0 0 (0%)
Doberman 1 (0.8%) 0 0 0 (0%) 0 1 1 (100%) 0 0 0 (0%)
English Basset 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 0 1 1 (50%)
Pinscher 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 1 0 1 (50%)
Beagle 1 (0.8%) 0 0 0 (0%) 0 1 1 (100%) 0 0 0 (0%)
WHW Terrier 1 (0.8%) 0 0 0 (0%) 1 0 1 (100%) 0 0 0 (0%)
Bergmask 
Sheepdog 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 0 1 1 (50%)
Croatian 
Sheepdog Tornjak 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 0 1 1 (50%)
English Cocker 
Spaniel 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 1 0 1 (50%)
Pitt Bull 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 0 1 1 (50%)
Alaskan 
Malamute 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 0 1 1 (50%)
French Bulldog 1 (0.8%) 0 0 0 (0%) 0 1 1 (100%) 0 0 0 (0%)
Argentinian 
Mastiff 1 (0.8%) 0 0 0 (0%) 0 0 0 (0%) 1 0 1 (50%)
 Total 21 10 31 31 21 52 25 17 42
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Table 4. Frequency of tumor grades in relation to the sex and age (number and %) dogs 
Grade Grade I. Grade II. Grade III. Total
Total 31 (24.8%) 52 (41.6%) 42 (33.6%) 125
Male 21 (67.74%) 31 (59.62%) 25 (59.53%) 77 (61.6%)
Female 10 (32.26%) 21 (40.38%) 17 (40.47%) 48 (38.4%)
% Male in total 
number of male 27.27 40.26 32.47 100
% Female in total 
number of female 20.83 43.75 35.42 100
Age 7.82 7.69 7.99 7.83
Table 5. Frequency of tumor grades in relation to the location of the tumor on the dogs 
Location Grade I. Grade II. Gradus III. Total
Head 5 (41.67%) 6 (50%) 1 (8.33%) 12 (9.6%)
Neck 3 (37.5%) 2 (25%) 3 (37.5%)  8 (6.4%)
Forelimb 2 (22.22%) 4 (44.44%) 3 (33.33%)  9 (7.20%)
Hind limb 5 (31.25%) 8 (50%) 3 (18.75%) 16 (12.8%)
Thorax 5 (23.80%) 8 (38.10%) 8 (38.10%) 21 (16.8%)
Back - 2 (100%) -  2 (1.6%)
Abdomen 3 (20%) 7 (46.67%) 5 (33.33%) 15 (12%)
Perineum - - 4 (100%)  4 (3.2%)
Tail - 1 (100%) -  1 (0.8%)
Scrotum 1 (20%) 1 (20%) 3 (60%)  5 (4.0%)
Preputium - 1 (100%) -  1 (0.8%)
Multiple - 2 (28%) 5 (71.43%)  7 (5.60%)
Not known 7 (29.17%) 10 (41.66%) 7 (29.17%) 24 (19.2%)
Total 31 52 42 125 (100%)
The dogs with MCSs included 32 breeds, and the most frequently affected breeds 
were Golden Retrievers (n = 26 or 20.8%), mongrels (n = 19 or 15.2%), and Boxers (n = 
14 or 11.2%) (Table 3).
Based on the Patnaik grading system, there were 31 (n = 21 or 67.74% in male dogs; 
n = 10 or 32.26% in female dogs) diagnosis of grade I MCSs, 52 grade II (n = 31 or 
59.61% in male; n = 21 or 40.38% in female) and 42 grade III (n = 25 or 59.53% in male; 
n = 17 or 40.47% in female). Grade I tumors were found in 24.8%, grade II in 41.6 and 
grade III in 33.6%. The males were more frequently affected than females. In male and 
female animals the most frequent grade of MCSs was grade II. The mean ages of the 
affected animals with grade I, II and III were 7.82, 7.69 and 7.99 respectively (Table 4).
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Concerning the localization and grade of MCSs, the most frequent localization was 
the thorax (n = 21), then the hind limbs (n = 16), the abdomen (n = 15), the head (n = 12), 
the forelimbs (n = 9), the neck (n = 8), multiple locations (n = 7), the scrotum (n = 5), the 
perineum (n = 4), the back (n = 2), the tail and preputium equally (n = 1), but in the 24 
cases of tumors the localization was unknown. On the thorax the most frequent grades 
were grades II and III equally, and then grade I, and the percentage was 38.10%, 38.10% 
and 23.80% respectively; on the hind limb grades II, I and III (50%, 31.25% and 18.75% 
respectively); on the abdomen grades II, III and I (46.67%, 33.33%, 20% respectively), 
on the head grades II, I and III (50%, 41.67%, 8.33% respectively), on the forelimb grades 
II, III and I (44.44%, 33.33% and 22.22% respectively), on the neck grades I and III 
equally then grade II (37.5%, 37.5% and 25% respectively), in multiple locations grade 
III and then grade II (71.43%, 28% respectively), on the scrotum grade III and then grade 
II and I equally (60%, 20%, 20% respectively), and on the perineum only grade III in 
4 animals was found (Table 5). The grade differences concerning the various breeds of 
animals are shown in Tables 6abc. 
Discussion
The results of this study reveal some interesting fi ndings regarding the incidence 
of MCSs, and their distribution according to sex, breed, age and localization in Croatia. 
Additionally, data concerning the frequency of tumor grades related to the location, breed 
and sex are also important fi ndings, which can be used in clinical practice. The majority 
of canine mast cell tumors occur in the skin and subcutis, and most MCSs originate 
in the dermis and extend into the subcutis, but there is subset that is confi ned to the 
subcutaneous fat (NEWMAN et al., 2007; THOMPSON et al., 2011). No histological grading 
system has been developed for subcutaneous MCSs. The results of THOMPSON’S study 
(2011) indicate that the majority of subcutaneous MCSs have a favorable prognosis. It 
is interesting that many pathologists describe subcutaneous MCSs as grade II tumors 
because of their subcutaneous location (PATNAIK et al,. 1984), but the majority of dogs 
with subcutaneous MCSs had prolonged survival times, increased disease-free intervals 
and lower rates of local reoccurrence and metastasis than with grade II cutaneous MCSs, 
and they are more effectively controlled by surgery than their cutaneous counterparts 
(THOMPSON et al., 2011). In our study, we analyzed subcutaneous and cutaneous MCSs 
using the Patnaik grading scheme. 
Concerning the overall prevalence of MCSs, our ratio is in concordance with the 
literature (BRODEY, 1970; PRIESTER, 1973; FINNIE and BOSTOCK, 1979; ROTHWELL, 
1987; MISDORP, 2004; BLACKWOOD et al., 2012). Literature data shows that the 
percentage of MCS was higher in females (intact and neutered) than in males (intact and 
neutered) dogs (GOLDSCHMIDT and SHOFER, 1998; GROSS et al., 2010). In our study, sex 
distribution differed from the literature data, i.e. MCSs were more frequently found in 
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males in comparison to females. The mean age of the affected animals with MCSs was 
7.83 years. This is generally in accordance with other literature data (GROSS et al., 2010).
In this study, 32 breeds of dog were affected with MCSs. The most frequent were 
Golden Retrievers, mongrels, Boxers, and Labrador Retrievers. The literature data 
described breed predilection to MCSs for a certain breed similar to our dana, but their 
frequency was different. In our case in fi rst place according to frequency were Golden 
Retrievers (which is in accordance with the results by NEWMAN et al., 2007) then 
mongrels, Boxers, Labrador Retrievers, Pugs, Staffordshire Terriers, Bullmastiffs etc. 
Several authors (GOLDSCHMIDT and SHOFER, 1998; SCOTT et al., 2001; RABANAL and 
FERRER 2002; GROSS et al., 2010) stated breed predilection for Boxers, Boston Terriers, 
Bull Terriers, English Bulldogs, Dachshunds, Labrador and Golden Retrievers, Beagles, 
Pugs, Shar Peis, Rhodesian Ridgebacks and Weimaraners. Similar to our fi ndings, 
THOMPSON (2011) recorded that Labrador Retrievers are the most affected breed. The 
previous studies of cutaneous MCSs reported that Boxers frequently develop multiple 
tumors (KIUPEL et al., 2005) but the outcomes are favorable (LONDON and SEGUIN, 2003). 
Also Pugs have less aggressive tumors (McNEIL, 2006), which suggests that there may be 
a genetic component to predisposition and tumor behavior.
Concerning the localization and grade of MCSs, our fi ndings are similar to the results 
of GOVIER (2003) and SIMPSON et al. (2004). Their data showed that the most frequent 
locations are the trunk, hind limbs, head and neck. In the work of NEWMAN et al. (2007), 
the most common locations for subcutaneous tumors are the hind limbs, forelimbs, 
abdomen, thorax, head/neck, back and tail. 
Considering sex predisposition, in our study all grades of mast cell tumors were more 
common in male animals. In both sexes the most frequent grade of MCSs was grade II. 
This is an interesting fi nding because in literature there are no data which describe sex 
as a risk factor. GROSS et al. (2010) stated that the majority of canine mast cell tumors are 
grades I and II, but in our study the most frequent grade in males and females was grade II, 
which is in accordance with some literature data (BUBIĆ ŠPOLJAR, 2007; GRABAREVIĆ 
et al., 2009). Although the histopathological grade is considered to be the gold standard 
for diagnosing MCSs, the high ratio of grade II and interobserver variation indicates the 
weaknesses of the Patnaik grading system. According to the data presented by KIUPEL et 
al. (2011) the most signifi cant variation in grading was between grades I and II. A 2-grade 
system of low-grade and high grade may be more appropriate and of greater clinical use. 
Tumor grades, in relation to the breed of dogs, are very similar to the previously described 
results (GRABAREVIĆ et al., 2009).
On the basis of our and previously cited literature dana, it is our opinion that in all 
histopathological analysis both methods („Patnaik’s“ and „Kiupel’s“) should be used. 
This fi nding would be helpful for deciding which method is more applicable for obtaining 
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a fi nal diagnosis and the grade of the MCTs. Subcutaneous MCTs should be separately 
analysed because of their different behavior.
_______
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SAŽETAK
Na Zavodu za veterinarsku patologiju Veterinarskog fakulteta u Zagrebu istraživana je pojavnost 
mastocitoma koji nastaju od tkivnih mastocita u dermisu i supkutisu u razdoblju od 1. siječnja 2008. do 
31. prosinca 2012. godine. Utvrđena je njihova pojava ovisno o spolu, pasmini, dobi i lokaciji te učestalost 
pojedinog stupnja tumora ovisno o pasmini, spolu i lokaciji. U analiziranom razdoblju zabilježeno je ukupno 
1939 tumora od kojih je bilo 928 tumora kože, a mastocitomi su utvrđeni u 125 životinja odnosno 13,47% od 
ukupnog broja tumora kože. Mastocitomi su bili najčešći u muških životinja (n = 77 ili 61,6%) prosječne dobi 
7,83 godine. Pojavnost tumora bila je najčešća na toraksu (16,8%), stražnjim udovima (12,8%), trbuhu (12%), 
prednjim udovima (7,20%) i vratu (6,4%). Najveća učestalost mastocitoma bila je u zlatnog retrivera. Stupanj 
I. tumora utvrđen je u 24,8% slučajeva (n = 31) od kojih su 67,74% bili mužjaci (n = 21), a 32,26% (n = 10) 
ženke; stupanj II. tumora u 41,6% (n = 52) od kojih su 59,62% (n = 31) bili mužjaci, a 40,38% (n = 21) ženke; 
stupanj III. tumora je utvrđen u 33,6% (n = 42) od kojih je 59,53 (n = 25) bilo mužjaka i 40,44 (n = 17) ženki. 
Udio stupnja I., II. i III. u mužjaka je bio retrospektivno 27,27%; 40,26% i 32,47%, a u ženki 20,83%; 43,75% 
and 35,42%. Prosječna dob životinja s tumorom stupnja I. iznosila 7,82 godine, stupnja II. 7,69, a s tumorom 
stupnja III. 7,99 godina. Na glavi je najčešće zabilježen stupanj II. tumora, na vratu podjednako stupanj I. i III., 
na prednjim i stražnjim udovima, leđima, trbuhu, repu i prepuciju najčešći je bio stupanj II. tumora dok je III. 
stupanj bio najčešći na perineumu, skrotumu te na multiplim lokacijama. U zlatnog retrivera tumor je najčešće 
bio ustanovljen na grudnom košu, u boksera na trbuhu, a u križanaca na različitim mjestima po tijelu.
Ključne riječi: mastocitomi, koža, učestalost, psi, Hrvatska________________________________________________________________________________________
